Bilici, A
1655  results:
Search for persons X
?
5

Pertuzumab, trastuzumab and taxane-based treatment for visc..:

Turkish Oncology Group ; Esin, Ece ; Oksuzoglu, B....
Cancer Chemotherapy and Pharmacology.  83 (2018)  1 - p. 131-143 , 2018
 
?
6

Economic Burden of Gastric Cancer in Turkey:

Bilici, A ; Gumus, M ; Malhan, S...
Value in Health.  20 (2017)  9 - p. A429 , 2017
 
?
7

Serum uric acid as a surrogate marker of favorable response..:

Selcukbiricik, F. ; Kanbay, M. ; Solak, Y....
Clinical and Translational Oncology.  18 (2016)  11 - p. 1082-1087 , 2016
 
?
8

The differences of clinicopathological factors for breast c..:

Oven Ustaalioglu, B. B. ; Balvan, O. ; Bilici, A....
Clinical and Translational Oncology.  17 (2015)  11 - p. 895-902 , 2015
 
?
9

Prognostic significance of ADAM17 expression in patients wi..:

Aydin, D. ; Bilici, A. ; Yavuzer, D....
Clinical and Translational Oncology.  17 (2015)  8 - p. 604-611 , 2015
 
?
10

Prognostic importance of RASSF2 expression in patients with..:

Aydin, D. ; Bilici, A. ; Kayahan, S....
Clinical and Translational Oncology.  18 (2015)  6 - p. 608-616 , 2015
 
?
11

Evaluation of orbital arteries with colour Doppler ultrason..:

Akkurt, Z. M. ; Gümüş, H. ; Aktürk, A....
Clinical and Experimental Dermatology.  40 (2015)  5 - p. 507-512 , 2015
 
?
 
?
 
1-15